Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2006 1
2010 1
2011 1
2013 2
2014 6
2015 10
2016 10
2017 5
2018 3
2019 3
2020 2
2021 7
2022 3
2023 7
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

60 results

Results by year

Filters applied: . Clear all
Page 1
Mnk inhibitors: a patent review.
Abdelaziz AM, Yu M, Wang S. Abdelaziz AM, et al. Among authors: yu m. Pharm Pat Anal. 2021 Jan;10(1):25-35. doi: 10.4155/ppa-2020-0028. Epub 2021 Jan 14. Pharm Pat Anal. 2021. PMID: 33441033
Circulating tumor DNA integrating tissue clonality detects minimal residual disease in resectable non-small-cell lung cancer.
Wang S, Li M, Zhang J, Xing P, Wu M, Meng F, Jiang F, Wang J, Bao H, Huang J, Ren B, Yu M, Qiu N, Li H, Yuan F, Zhang Z, Jia H, Lu X, Zhang S, Wang X, Xu Y, Xia W, Liu T, Xu W, Xu X, Sun M, Wu X, Shao Y, Wang Q, Dai J, Qiu M, Wang J, Zhang Q, Xu L, Shen H, Yin R. Wang S, et al. Among authors: yu m. J Hematol Oncol. 2022 Oct 1;15(1):137. doi: 10.1186/s13045-022-01355-8. J Hematol Oncol. 2022. PMID: 36183093 Free PMC article.
CDK5 in oncology: recent advances and future prospects.
Lenjisa JL, Tadesse S, Khair NZ, Kumarasiri M, Yu M, Albrecht H, Milne R, Wang S. Lenjisa JL, et al. Among authors: yu m. Future Med Chem. 2017 Oct;9(16):1939-1962. doi: 10.4155/fmc-2017-0097. Epub 2017 Oct 27. Future Med Chem. 2017. PMID: 29076761 Review.
Targeting CDK9: a promising therapeutic opportunity in prostate cancer.
Rahaman MH, Kumarasiri M, Mekonnen LB, Yu M, Diab S, Albrecht H, Milne RW, Wang S. Rahaman MH, et al. Among authors: yu m. Endocr Relat Cancer. 2016 Dec;23(12):T211-T226. doi: 10.1530/ERC-16-0299. Epub 2016 Aug 31. Endocr Relat Cancer. 2016. PMID: 27582311 Review.
MAP kinase-interacting kinases--emerging targets against cancer.
Diab S, Kumarasiri M, Yu M, Teo T, Proud C, Milne R, Wang S. Diab S, et al. Among authors: yu m. Chem Biol. 2014 Apr 24;21(4):441-452. doi: 10.1016/j.chembiol.2014.01.011. Epub 2014 Mar 6. Chem Biol. 2014. PMID: 24613018 Review.
60 results